Skip to main content

$1.55 -0.01 (-0.32%)

High

$1.56

Low

$1.52

Trades

1,747

Turnover

$1,891,056

Volume

1,225,647
30 June 2023 at 4:10pm
Register to track PNV and receive email alerts.
Subject
PNV Article: RBNZ lifts rates 0.75pc to 4.25pc in record high increase

PNV Ann: Completion of $30m Institutional Placement

PNV Article: ASX hits five-month high; coal stocks rally; Iris Energy craters

PNV Ann: Proposed issue of securities - PNV

PNV Ann: Investor Presentation

PNV Ann: Capital Raising

PNV Article: PolyNovo in $50m equity raising; Mac, Bells on the ticket

PNV Ann: Trading Halt

PNV Ann: Chairman's address at Bell Potter Healthcare Conference

PNV Ann: PolyNovo enters India market

PNV Ann: AGM 2022 - Webcast Recording

PNV Ann: Results of 2022 Annual General Meeting

PNV Ann: Chairman and CEO - AGM address to shareholders

PNV Ann: Hong Kong - Two cases, Two surgeons

PNV Ann: Canada - NovoSorb BTM registration approved

PNV Ann: Director Share Purchase - David Williams

PNV Ann: Director Share Purchase - David Williams

PNV Ann: Director Share Purchase - David Williams

PNV Ann: Director Share Purchase - David Williams

PNV Ann: Director Share Purchase - David Williams

PNV Article: Burns treatment biotech soars 13pc on record sales month

PNV Ann: Q1 FY23 Sales Result

PNV Ann: Notice of Annual General Meeting

PNV Ann: Annual Report 2022

PNV Ann: Becoming a substantial holder

PNV Ann: FDA 510(k) clearance for NovoSorb MTX

PNV Article: PolyNovo set for FDA clearance of new US product

PNV Ann: Trading halt

PNV Ann: Pause in trading

PNV Ann: Final Director's Interest Notice

PNV Ann: Director resignation & appointment Chief Tech & Sci Officer

PNV Article: PolyNovo shares slide 13pc after earnings miss

PNV Ann: PolyNovo FY22 Briefing Session

PNV Ann: Corporate Governance Statement

PNV Ann: Appendix 4G

PNV Ann: FY22 Results Presentation

PNV Ann: Appendix 4E and FY22 Financial Statements

PNV Ann: FY22 Results Webcast details

PNV Ann: First Patient enrolled - SynPath Diabetic Foot Ulcer Trial

PNV Ann: Victorian Government Grant - Diabetic Foot Ulcer Product

PNV Ann: Recording of Webcast with Chairman and New CEO

PNV Ann: Webcast with the Chairman and New CEO

PNV Article: ASX closes at seven-week peak, Sezzle and Zip tumble

PNV Article: PolyNovo soars after snaring J&J veteran as new CEO

PNV Ann: CEO Appointment - Swami Raote

PNV Ann: Ceasing to be a substantial holder from MUFG

PNV Ann: Becoming a substantial holder from MUFG

PNV Ann: Ceasing to be a substantial holder

PNV Ann: Ceasing to be a substantial holder

PNV Ann: Becoming a substantial holder

Register to track PNV and receive email alerts.

Similar Companies

ANN
AVR
MGZ
NAN
NXS
OSX
SDI
SDI